SC
SPRO icon

Steven Cohen’s Spero Therapeutics SPRO Stock Holding History

Steven Cohen’s Portfolio SPRO Stock Details SPRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231K Buy
104,377
+44,709
+75% +$117K ﹤0.01% 3481
2026
Q1 		$140K Buy
59,668
+16,089
+37% +$38.2K ﹤0.01% 3577
2025
Q4 		$102K Buy
+43,579
New +$101K ﹤0.01% 3739
2018
Q4 		– Sell
-44,000
Closed -$462K – 1185
2018
Q3 		$462K Buy
+44,000
New +$511K ﹤0.01% 932

Other funds holding SPRO

GP
GSK plc London $602M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Steven Cohen's SPRO Position: Q2 2026 in Review

Steven Cohen increased its Spero Therapeutics (SPRO) stake by 75% in Q2 2026, buying an estimated $117K and bringing the position to 104,377 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #3481.

Steven Cohen first reported a position in SPRO in Q3 2018 and has held it in 4 quarters since. The position peaked at $462K in Q3 2018. 60 funds tracked by Wall St. Rank hold SPRO as of Q2 2026.

  • Steven Cohen held 104,377 shares of Spero Therapeutics worth $231K as of Q2 2026.
  • Steven Cohen bought 44,709 Spero Therapeutics shares in Q2 2026, an estimated $117K.
  • Spero Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #3481 holding.
  • Steven Cohen first reported a position in Spero Therapeutics in Q3 2018 and has held it in 4 quarters since.
  • Steven Cohen's Spero Therapeutics position peaked at $462K in Q3 2018.
  • 60 funds tracked by Wall St. Rank held Spero Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.